Got a tip?: tips@bullonthestreet.com
Email: info@bullonthestreet.com

Posts Tagged ‘FDA’

Novartis to Buy Cancer Drug Company Endocyte for $2.1 Billion

Swiss pharmaceutical giant Novartis is making a big acquisition under its new chief executive, Vasant Narasimhan. The company announced that it would be buying U.S. cancer drug maker Endocyte Inc. for $2.1 billion, or $24 a share for the company, in cash. Endocyte, which specializes in so-called radiopharmaceuticals, is developing a new treatment for prostate…

Read More

Sanofi and Regeneron Gain FDA Approval for Skin Cancer Drug

Regeneron Pharmaceuticals Inc. and Sanofi have received approval from the U.S. Food and Drug Administration for the duo’s first immuno-oncology drug called Libtayo. Libtayo has been approved by the FDA for the treatment of a common type of metastatic skin cancers that previously had no treatment called metastatic cutaneous squamous cell carcinoma (CSCC). The medication…

Read More

LaCroix is Sued Over Allegations That the Company Mislabeled its Sparkling Water

Sparkling water company LaCroix has been hit with a lawsuit that alleges the company’s products include non-natural and synthetic compounds. According to the lawsuit, which was filed in Cook County, Illinois, LaCrois’s products contain ethyl butanoate, limonene, linalool and linalool propionate. Just to get an idea of how bad these chemicals are, Linalool is often…

Read More

Tobacco Stocks See Massive Gains as FDA Cracks Down on E-cig Makers

Tobacco stocks were on the rise after an announcement from the Food and Drug Administration revealed that the organization would be cracking down on teenager use of e-cigarettes. The FDA is going after e-cig manufacturers and has threatened to pull e-cigs from their shelves if they do not control the “widespread” teen use. Brands being…

Read More

AstraZeneca and Amgen Get FDA Breakthrough Therapy Label for Asthma Drug

AstraZeneca Plc and Amgen Inc (NASDAQ:AMGN) announced that the U.S. Food and Drug Administration has granted a breakthrough therapy label for the two companys’ drug Tezepelumab. Tezepelumab, an injectable treatment, is intended to treat a type of severe asthma. The breakthrough therapy label potentially speeds up the development and regulatory review. According to data from…

Read More